Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1886 1
1890 1
1892 1
1893 1
1894 3
1896 4
1898 1
1899 1
1925 1
1926 1
1928 1
1929 1
1932 2
1933 1
1934 2
1935 2
1936 1
1937 1
1945 3
1946 10
1947 17
1948 18
1949 18
1950 31
1951 37
1952 30
1953 60
1954 52
1955 77
1956 80
1957 69
1958 68
1959 68
1960 76
1961 84
1962 112
1963 172
1964 237
1965 190
1966 207
1967 246
1968 256
1969 274
1970 273
1971 290
1972 278
1973 313
1974 263
1975 270
1976 299
1977 253
1978 231
1979 287
1980 259
1981 262
1982 342
1983 304
1984 376
1985 435
1986 467
1987 563
1988 569
1989 740
1990 820
1991 843
1992 849
1993 1105
1994 1126
1995 1178
1996 1268
1997 1520
1998 1635
1999 1754
2000 2013
2001 2182
2002 2446
2003 2612
2004 2948
2005 3202
2006 3215
2007 3191
2008 3363
2009 3499
2010 3695
2011 4048
2012 4121
2013 4253
2014 4407
2015 4648
2016 4636
2017 4708
2018 4887
2019 4939
2020 5566
2021 5976
2022 5870
2023 5746
2024 6393
2025 7360
2026 4834

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123,588 results

Results by year

Filters applied: . Clear all
Page 1
Postmenopausal Osteoporosis: A Review of Latest Guidelines.
Subarajan P, Arceo-Mendoza RM, Camacho PM. Subarajan P, et al. Endocrinol Metab Clin North Am. 2024 Dec;53(4):497-512. doi: 10.1016/j.ecl.2024.08.008. Epub 2024 Oct 5. Endocrinol Metab Clin North Am. 2024. PMID: 39448132 Review.
Osteoporosis is characterized by increased bone turnover and reduced bone mass, leading to skeletal fragility and heightened fracture risk. ...Emerging therapies and ongoing research continue to evolve the landscape of osteoporosis management, aiming to reduce fract …
Osteoporosis is characterized by increased bone turnover and reduced bone mass, leading to skeletal fragility and heightened fracture …
Postmenopausal Osteoporosis.
Walker MD, Shane E. Walker MD, et al. N Engl J Med. 2023 Nov 23;389(21):1979-1991. doi: 10.1056/NEJMcp2307353. N Engl J Med. 2023. PMID: 37991856 Review. No abstract available.
Long-Term Treatment of Postmenopausal Osteoporosis.
Brown JP. Brown JP. Endocrinol Metab (Seoul). 2021 Jun;36(3):544-552. doi: 10.3803/EnM.2021.301. Epub 2021 Jun 22. Endocrinol Metab (Seoul). 2021. PMID: 34154042 Free PMC article.
This publication addresses how best to use the pharmacological options available for postmenopausal osteoporosis to provide lifelong fracture protection in patients at high and very high risk of fracture. The benefit of osteoporosis therapies far outweighs th …
This publication addresses how best to use the pharmacological options available for postmenopausal osteoporosis to provide li …
T-Cell Mediated Inflammation in Postmenopausal Osteoporosis.
Wu D, Cline-Smith A, Shashkova E, Perla A, Katyal A, Aurora R. Wu D, et al. Front Immunol. 2021 Jun 30;12:687551. doi: 10.3389/fimmu.2021.687551. eCollection 2021. Front Immunol. 2021. PMID: 34276675 Free PMC article. Review.
Several factors contribute to osteoporosis in men and women. In women, menopause - the cessation of ovarian function, is one of the leading causes of primary osteoporosis. Over the past three decades there has been growing appreciation that the adaptive immune syste …
Several factors contribute to osteoporosis in men and women. In women, menopause - the cessation of ovarian function, is one of the l …
Recent Advances in Osteoporosis Therapeutics.
Sølling AS, Langdahl BL, Cosman F. Sølling AS, et al. Annu Rev Med. 2026 Jan;77(1):433-448. doi: 10.1146/annurev-med-050124-040555. Epub 2025 Nov 18. Annu Rev Med. 2026. PMID: 41252575 Free article. Review.
Postmenopausal osteoporosis is a chronic progressive disease related to estrogen deficiency at menopause, aging, and superimposed genetic and environmental factors. ...New treatments under investigation also hold promise for further improving bone health in postm …
Postmenopausal osteoporosis is a chronic progressive disease related to estrogen deficiency at menopause, aging, and superimpo …
Postmenopausal Osteoporosis: Latest Guidelines.
Arceo-Mendoza RM, Camacho PM. Arceo-Mendoza RM, et al. Endocrinol Metab Clin North Am. 2021 Jun;50(2):167-178. doi: 10.1016/j.ecl.2021.03.009. Endocrinol Metab Clin North Am. 2021. PMID: 34023036 Review.
Significant development has occurred in the treatment of postmenopausal osteoporosis. We review the most recent guidelines from the American Association of Clinical Endocrinologists/American College of Endocrinology, Endocrine Society, and the European Society for C …
Significant development has occurred in the treatment of postmenopausal osteoporosis. We review the most recent guidelines fro …
Interaction between bone and immune cells: Implications for postmenopausal osteoporosis.
Fischer V, Haffner-Luntzer M. Fischer V, et al. Semin Cell Dev Biol. 2022 Mar;123:14-21. doi: 10.1016/j.semcdb.2021.05.014. Epub 2021 May 20. Semin Cell Dev Biol. 2022. PMID: 34024716 Free article. Review.
Postmenopausal osteoporosis is a systemic disease characterized by the loss of bone mass and increased bone fracture risk largely resulting from significantly reduced levels of the hormone estrogen after menopause. ...Consequently, in addition to the direct negative …
Postmenopausal osteoporosis is a systemic disease characterized by the loss of bone mass and increased bone fracture risk larg …
Estrogen deficiency-mediated osteoimmunity in postmenopausal osteoporosis.
Yao Y, Cai X, Chen Y, Zhang M, Zheng C. Yao Y, et al. Med Res Rev. 2025 Mar;45(2):561-575. doi: 10.1002/med.22081. Epub 2024 Sep 5. Med Res Rev. 2025. PMID: 39234932 Review.
Postmenopausal osteoporosis (PMO) is a common disease associated with aging, and estrogen deficiency is considered to be the main cause of PMO. ...In this review, we systematically describe the progress of the mechanisms of bone loss in PMO, estrogen deficiency-medi …
Postmenopausal osteoporosis (PMO) is a common disease associated with aging, and estrogen deficiency is considered to be the m …
Clinical Practice. Postmenopausal Osteoporosis.
Black DM, Rosen CJ. Black DM, et al. N Engl J Med. 2016 Jan 21;374(3):254-62. doi: 10.1056/NEJMcp1513724. N Engl J Med. 2016. PMID: 26789873 Review.
Key Clinical Points Postmenopausal Osteoporosis Fractures and osteoporosis are common, particularly among older women, and hip fractures can be devastating. ...Osteonecrosis of the jaw and atypical femur fractures have been reported with treatment but are rar …
Key Clinical Points Postmenopausal Osteoporosis Fractures and osteoporosis are common, particularly among older women, …
Immunoporosis: Role of immune system in the pathophysiology of different types of osteoporosis.
Zhang W, Gao R, Rong X, Zhu S, Cui Y, Liu H, Li M. Zhang W, et al. Front Endocrinol (Lausanne). 2022 Sep 6;13:965258. doi: 10.3389/fendo.2022.965258. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36147571 Free PMC article. Review.
Classical theories hold that osteoporosis is essentially a bone remodeling disorder caused by estrogen deficiency/aging (primary osteoporosis) or secondary to diseases/drugs (secondary osteoporosis). ...In postmenopausal osteoporosis, estrogen d …
Classical theories hold that osteoporosis is essentially a bone remodeling disorder caused by estrogen deficiency/aging (primary o …
123,588 results
You have reached the last available page of results. Please see the User Guide for more information.